BioNTech COVID-19 vaccine for ages 5 to 11 years – To jab or not to jab?

3 Nov 2021

Catalina FOK

This content is sponsored. It is intended for healthcare professionals only.

COVID-19 vaccines have been approved for use early in 2021, with the BioNTech mRNA vaccine (Comirnaty®) being one of the first vaccines made widely available in the market. The BNT162b2 vaccine, which carries a nucleoside-modified messenger RNA encoding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein, produces a high serum neutralising antibody titre and antigen-specific T-cell response when administered in two 30µg doses in healthy adults.

Pfizer-BioNTech-COVID-19-Vaccine-for-Ages-5-to-11-Years

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.

BioNTech COVID-19 vaccine for ages 5 to 11 years – To jab or not to jab?

Related posts